Pharmaceutical industry

The increased cumulation of epidemiological as well as molecular biological know-how in regard to genetically caused inflammatory diseases will expand the potential for a chronic venous disease therapy in the long run. We want to actively take part in translational medicine. We actively perform studies within the scope of our possibilities and we are looking forward to additional cooperation partners from the pharmaceutical industry in order to achieve our goals.